These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 12623121)
21. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors. Müller C; Schubiger PA; Schibli R Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798 [TBL] [Abstract][Full Text] [Related]
22. Labeling of epirubicin with technetium-99m: Optimization, biodistribution and scintigraphic imaging in tumor bearing mice. Hina S; Bokhari TH; Roohi S; Rajoka MI; Sohaib M Pak J Pharm Sci; 2018 Mar; 31(2):517-524. PubMed ID: 29618443 [TBL] [Abstract][Full Text] [Related]
23. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070 [TBL] [Abstract][Full Text] [Related]
25. Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of Pham TT; Hungnes IN; Rivas C; Cleaver J; Firth G; Blower PJ; Sosabowski J; Cook GJR; Livieratos L; Young JD; Pringle PG; Ma MT J Nucl Med; 2024 Jul; 65(7):1087-1094. PubMed ID: 38844360 [TBL] [Abstract][Full Text] [Related]
26. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re. van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu? Vallabhajosula S; Kuji I; Hamacher KA; Konishi S; Kostakoglu L; Kothari PA; Milowski MI; Nanus DM; Bander NH; Goldsmith SJ J Nucl Med; 2005 Apr; 46(4):634-41. PubMed ID: 15809486 [TBL] [Abstract][Full Text] [Related]
28. Investigations of 99mTc morpholino pretargeting in mice. Liu G; Liu C; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ Nucl Med Commun; 2003 Jun; 24(6):697-705. PubMed ID: 12766607 [TBL] [Abstract][Full Text] [Related]
29. Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3. Mohsin H; Fitzsimmons J; Shelton T; Hoffman TJ; Cutler CS; Lewis MR; Athey PS; Gulyas G; Kiefer GE; Frank RK; Simon J; Lever SZ; Jurisson SS Nucl Med Biol; 2007 Jul; 34(5):493-502. PubMed ID: 17591549 [TBL] [Abstract][Full Text] [Related]
30. Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases. Ogawa K; Kawashima H; Shiba K; Washiyama K; Yoshimoto M; Kiyono Y; Ueda M; Mori H; Saji H Nucl Med Biol; 2009 Feb; 36(2):129-35. PubMed ID: 19217524 [TBL] [Abstract][Full Text] [Related]
31. Successful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue. Liu G; Dou S; Mardirossian G; He J; Zhang S; Liu X; Rusckowski M; Hnatowich DJ Clin Cancer Res; 2006 Aug; 12(16):4958-64. PubMed ID: 16914585 [TBL] [Abstract][Full Text] [Related]
32. Techniques for loading technetium-99m and rhenium-186/188 radionuclides into pre-formed liposomes for diagnostic imaging and radionuclide therapy. Goins B; Bao A; Phillips WT Methods Mol Biol; 2010; 606():469-91. PubMed ID: 20013416 [TBL] [Abstract][Full Text] [Related]
33. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice. Liu G; Dou S; He J; Liu X; Rusckowski M; Hnatowich DJ Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815 [TBL] [Abstract][Full Text] [Related]
34. Cytosine residues influence kidney accumulations of 99mTc-labeled morpholino oligomers. Liu G; He J; Zhang S; Liu C; Rusckowski M; Hnatowich DJ Antisense Nucleic Acid Drug Dev; 2002 Dec; 12(6):393-8. PubMed ID: 12568313 [TBL] [Abstract][Full Text] [Related]
35. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy. Goins B; Bao A; Phillips WT Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538 [TBL] [Abstract][Full Text] [Related]
36. Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector. Liu G; Dou S; Pretorius PH; Liu X; Chen L; Rusckowski M; Hnatowich DJ Q J Nucl Med Mol Imaging; 2010 Jun; 54(3):333-40. PubMed ID: 20639818 [TBL] [Abstract][Full Text] [Related]
37. Versatile synthetic approach to new bifunctional chelating agents tailor made for labeling with the fac-[M(CO)(3)](+) core (M = Tc, (99m)Tc, Re): synthesis, in vitro, and in vivo behavior of the model complex [M(APPA)(CO)(3)] (APPA = [(5-amino-pentyl)-pyridin-2-yl-methyl-amino]-acetic acid). Stichelberger A; Waibel R; Dumas C; Schubiger PA; Schibli R Nucl Med Biol; 2003 Jul; 30(5):465-70. PubMed ID: 12831983 [TBL] [Abstract][Full Text] [Related]
38. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640 [TBL] [Abstract][Full Text] [Related]
39. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds. Knapp FF; Guhlke S; Beets AL; Lin WY; Stabin M; Amols H; Weinberger J Cardiovasc Radiat Med; 1999; 1(1):86-97. PubMed ID: 11272362 [TBL] [Abstract][Full Text] [Related]
40. Preparation, radiolabeling with de Arcocha-Torres M; Quincoces G; Martínez-López AL; Erhard A; Collantes M; Martínez-Rodríguez I; Ecay M; Banzo I; Irache JM; Peñuelas I Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):225-232. PubMed ID: 32201272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]